LifenolTM, a clinically proven hops extract for menopause symptoms, was recognised in the Healthy Ageing Ingredient Innovation category.
Givaudan, a global leader in taste and wellbeing, is proud to announce that it has received an award for LifenolTM at the Vitafoods Europe Innovation Awards, held on May 20th in Barcelona. The award highlights Givaudan’s leadership in delivering scientifically backed, botanical ingredients, which contribute to outstanding wellness experiences for consumers globally.
“We’re delighted to win this award for LifenolTM, our science-backed hops extract that supports women’s health as they age,” said Stephane Dupuits, Head of the Health & Functional Business Unit, Givaudan. “It reflects our commitment to deliver effective and trusted health solutions that taste great and support proactive health and wellbeing.”
Givaudan’s Lifenol™: the natural ingredient to improve menopausal quality of life
Powered by a patented hops extract and awarded health claims, Lifenol™ has been proven in gold-standard clinical trials to relieve uncomfortable menopausal symptoms,¹ ² such as hot flashes, while also supporting total bone-mineral density.³ Lifenol™ offers scientifically-substantiated benefits for menopause. It’s a natural way to improve menopausal quality of life.
Lifenol™ is a natural, low-dose solution delivering effective phytoestrogen, prenylnaringenin (8-PN). A single 85 mg dose has been clinically shown to alleviate distressing menopausal symptoms such as hot flashes and sleep problems in two separate studies. ² ³ It is also clinically demonstrated to support bone health.³
For more information about Givaudan’s botanical ingredients and expertise in health solutions, please visit the Givaudan Health Solutions Hub.
References
1. Erkkola, R. et al. (2010) ‘A randomised, double-blind, placebo-controlled, cross-over pilot study on the use of a standardised hop extract to alleviate menopausal discomforts’, Phytomedicine, 17(6):389-396.
2. Heyerick, A. et al. (2006) ‘A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts’, Maturitas, 54(2):164-175.
3. Lecomte, M. et al. (2023) ‘Effect of a hop extract standardised in 8-prenylnaringenin on bone health and gut microbiome in postmenopausal women with osteopenia: a one-year randomised, double-blind, placebo-controlled trial’, Nutrients, 15(12):2688.
